{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-012233","form_type":"8-K","ticker":"CPRX","cik":"0001369568","company_name":"CATALYST PHARMACEUTICALS, INC.","filed_at":"2025-01-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.449563+00:00","generated_at":"2026-05-27T10:38:08.039679+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Catalyst Pharma director O'Keeffe to retire; not standing for reelection at 2025 meeting","bullets":["Charles B. O'Keeffe, 85, will not stand for reelection at the 2025 annual meeting; term ends at that meeting.","O'Keeffe has served as independent director since 2004, currently Lead Independent Director.","Retirement not due to any disagreement with company on operations, policies, or practices.","Corporate Governance Committee will hire a recruitment firm to search for a replacement director."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-012233","json":"https://secwatch.observer/filing/0001193125-25-012233.json","markdown":"https://secwatch.observer/filing/0001193125-25-012233.md","text":"https://secwatch.observer/filing/0001193125-25-012233.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1369568/000119312525012233/0001193125-25-012233-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1369568/000119312525012233/d911150d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T10:38:08.039679+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b098f128d4","claim":"Charles B. O’Keeffe departed as Lead Independent Director at CATALYST PHARMACEUTICALS, INC..","evidence_excerpt":"On January 17, 2025, Charles B. O’Keeffe, an independent member of the Board of Directors (“Board”) of Catalyst Pharmaceuticals, Inc. (the “Company”), advised the Company of his decision to not stand for reelection at the 2025 annual meeting of the Company’s stockholders.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1369568/000119312525012233/0001193125-25-012233-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retire"},{"label":"Role","value":"Lead Independent Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}